시장보고서
상품코드
1908532

의료용 레이저 시스템 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2026-2033년)

Medical Laser Systems Market Size, Share & Trends Analysis Report By Product (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers), By Application (Dermatology, Ophthalmology, Gynecology, Urology), By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 레이저 시스템 시장 개요

세계의 의료용 레이저 시스템 시장 규모는 2025년 44억 4,000만 달러로 평가되었고, 2033년 97억 2,000만 달러에 이를 것으로 예측됩니다.

2026-2033년에 걸쳐 CAGR 10.38%로 성장할 전망입니다. 이 시장 성장은 정밀도와 회복 시간 단축이 중요한 안과, 비뇨기과, 피부과, 치과, 종양학 등 다양한 전문 부문에서 최소 침습 시술에 대한 수요 증가에 의해 주도되고 있습니다.

만성 질환 및 노화 관련 질환의 유병률 증가와 레이저 플랫폼의 지속적인 기술 발전이 결합되어 병원 및 전문 클리닉 전반에 걸쳐 도입이 더욱 가속화되고 있습니다. 미국 성형외과학회(ASPS)의 2024년 시술 통계 보고서에 따르면, 2024년 최소 침습 주사 치료는 3% 증가하여 수술적 미용 시술을 크게 앞질렀습니다. 이러한 성장은 비용 절감과 회복 기간 단축에 힘입어 해당 연도 동안 2,850만 건 이상의 최소 침습 시술이 시행된 결과입니다.

환자와 의료진 모두 외상, 불편감, 회복 시간을 줄이는 시술을 선호함에 따라 최소 침습적 치료에 대한 선호도 증가는 의료용 레이저 시스템 산업의 핵심 성장 동력입니다. 의료용 레이저는 주변 조직 손상을 최소화하면서 높은 정밀도를 제공하여 기존 수술에 비해 합병증 발생률이 낮고 회복 기간이 빠르다. 이러한 안전하고 외래 중심의 치료로의 전환은 피부과, 안과, 치과 및 다양한 수술 부문에 걸쳐 레이저 기술 활용을 촉진하고 있습니다.

자주 묻는 질문

  • 의료용 레이저 시스템 시장 규모는 어떻게 예측되나요?
  • 의료용 레이저 시스템 시장의 성장 요인은 무엇인가요?
  • 2024년 최소 침습 주사 치료의 성장률은 어떻게 되나요?
  • 의료용 레이저 시스템의 주요 이점은 무엇인가요?
  • 의료용 레이저 시스템 시장에서 선호되는 치료 방식은 무엇인가요?
  • 의료용 레이저 시스템 시장의 주요 응용 분야는 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 레이저 시스템 시장의 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 관련/보조시장 전망
  • 시장 역학
  • 의료용 레이저 시스템 시장 분석 도구
    • Porter's Five Forces 분석
    • PESTEL 분석

제4장 의료용 레이저 시스템 시장 : 제품별, 추정 및 동향 분석

  • 세계의 의료용 레이저 시스템 시장 : 제품별 변동 분석(2025년, 2033년)
  • 세계의 의료용 레이저 시스템 시장 규모와 동향 분석(제품별, 2021-2033년)
  • 다이오드 레이저
  • 고체 레이저
  • 가스 레이저
  • 염료 레이저

제5장 의료용 레이저 시스템 시장 : 용도별, 추정 및 동향 분석

  • 세계의 의료용 레이저 시스템 시장 : 용도별 변동 분석(2025년, 2033년)
  • 세계의 의료용 레이저 시스템 시장 규모와 동향 분석(용도별, 2021-2033년)
  • 피부과
  • 안과
  • 부인과
  • 비뇨기과
  • 치과
  • 이비인후과
  • 기타

제6장 의료용 레이저 시스템 시장 : 제품, 용도, 지역별, 추정 및 동향 분석

  • 지역별 대시보드
  • 시장 규모와 동향 분석(2021-2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 스웨덴
    • 덴마크
    • 노르웨이
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제7장 경쟁 구도

  • 주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
  • 기업 분류
  • 기업 점유율 분석(2025년)
  • 기업 히트맵 분석
  • 전략 매핑
    • 사업 확대
    • 합병 및 인수
    • 제휴 및 협업
    • 신제품 발매
    • 연구개발
    • 기업 프로파일
    • LumIR Laser
    • Boston Scientific Corporation
    • Candela Corporation
    • Koninklijke Philips NV
    • BIOLASE MG LLC(MEGA'GEN IMPLANT CO.,LTD.)
    • IRIDEX Corporation
    • Biolitec Holding GmbH & Co KG
    • Olympus
    • Cutera
    • Alcon
    • Carl Zeiss Meditec AG
    • Bausch Lomb
    • El.En. Sp.A.
    • Johnson & Johnson
    • Fotona
HBR 26.01.22

Medical Laser Systems Market Summary

The global medical laser systems market size was estimated at USD 4.44 billion in 2025 and is projected to reach USD 9.72 billion by 2033, growing at a CAGR of 10.38% from 2026 to 2033. The market growth is driven by the rising demand for minimally invasive procedures across various specialties, including ophthalmology, urology, dermatology, dentistry, and oncology, where precision and reduced recovery times are critical.

The rising prevalence of chronic diseases and age-related conditions, combined with continuous technological advancements in laser platforms, is further accelerating adoption across hospitals and specialty clinics. According to the American Society of Plastic Surgeons' 2024 Procedural Statistics Report, minimally invasive injectable treatments increased by 3% in 2024, outpacing surgical cosmetic procedures by a significant margin. This growth was driven by lower costs and shorter recovery times, resulting in more than 28.5 million minimally invasive procedures performed during the year.

The growing preference for minimally invasive treatments is a key driver of the medical laser systems industry, as both patients and clinicians seek procedures that reduce trauma, discomfort, and recovery time. Medical lasers offer high precision while minimizing damage to surrounding tissue, resulting in fewer complications and quicker healing times compared to traditional surgery. This shift toward safer, outpatient-based care is boosting the use of laser technologies across dermatology, ophthalmology, dentistry, and various surgical applications.

Global Medical Laser Systems Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical laser systems market report based on product, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diode Lasers
  • Solid State Lasers
    • Holmium Yttrium Aluminum Garnet (Ho:YAG) lasers
    • Erbium Yttrium Aluminum Garnet (Er:YAG) lasers
    • Neodynium Yttrium Aluminum Garnet (Nd:YAG) lasers
    • Potassium Titanyl Phosphate (KTP)
    • Alexandrite lasers
    • Ruby lasers
  • Gas Lasers
    • Co2 laser
    • Argon laser
    • Krypton laser
    • Metal Vapor (Au & Cu) laser
    • Helium-Neon laser
    • Excimer laser
  • Dye Lasers
  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Dermatology
  • Ophthalmology
  • Gynecology
  • Urology
  • Dentistry
  • ENT
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Laser Systems Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising demand for minimally invasive treatments
      • 3.2.1.2. Increasing prevalence of age-related eye disorders
      • 3.2.1.3. Expanding clinical applications across multiple medical specialties
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High capital investment and maintenance costs
      • 3.2.2.2. Shortage of trained professionals
      • 3.2.2.3. Strict regulatory and clinical approval requirements
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Technological advancements
      • 3.2.3.2. Development of combination therapies
      • 3.2.3.3. Growth opportunities across emerging economies
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Challenges in Reimbursement Scenario
  • 3.3. Medical Laser Systems Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Medical Laser Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Medical Laser Systems Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Medical Laser Systems Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Diode Lasers
    • 4.4.1. Diode lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Solid State Lasers
    • 4.5.1. Solid state lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Holmium Yttrium Aluminum Garnet (Ho:YAG) Lasers
        • 4.5.1.1.1. Holmium yttrium aluminum garnet (Ho:YAG) lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Erbium Yttrium Aluminum Garnet (Er:YAG) Lasers
        • 4.5.1.2.1. Erbium yttrium aluminum garnet (Er:YAG) lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.3. Neodymium Yttrium Aluminum Garnet (Nd:YAG) Lasers
        • 4.5.1.3.1. Neodymium yttrium aluminum garnet (Nd:YAG) lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.4. Potassium Titanyl Phosphate (KTP)
        • 4.5.1.4.1. Potassium titanyl phosphate (KTP) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.5. Alexandrite Lasers
        • 4.5.1.5.1. Alexandrite lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.6. Ruby Lasers
        • 4.5.1.6.1. Ruby lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Gas Lasers
    • 4.6.1. Gas lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.1. Co2 Lasers
        • 4.6.1.1.1. CO2 lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.2. Argon Lasers
        • 4.6.1.2.1. Argon lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.3. Krypton Lasers
        • 4.6.1.3.1. Krypton lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.4. Metal Vapor (Au & Cu) Lasers
        • 4.6.1.4.1. Metal vapor (Au & Cu) lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.5. Helium-Neon Lasers
        • 4.6.1.5.1. Helium-neon lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.6. Excimer Lasers
        • 4.6.1.6.1. Excimer lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Dye Lasers
    • 4.7.1. Dye lasers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Medical Laser Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Medical Laser Systems Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Medical Laser Systems Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Dermatology
    • 5.4.1. Dermatology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ophthalmology
    • 5.5.1. Ophthalmology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Gynecology
    • 5.6.1. Gynecology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Urology
    • 5.7.1. Urology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Dentistry
    • 5.8.1. Dentistry market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. ENT
    • 5.9.1. ENT market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical Laser Systems Market: Regional Estimates & Trend Analysis by Product and Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. North America medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. UK medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. Germany medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. France medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Italy medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Spain medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Denmark medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Competitive scenario
      • 6.4.9.3. Regulatory framework
      • 6.4.9.4. Reimbursement scenario
      • 6.4.9.5. Norway medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. China medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Japan medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. India medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. South Korea medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Australia medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Competitive scenario
      • 6.5.7.3. Regulatory framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. Thailand medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Brazil medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Argentina medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. Middle East and Africa medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. South Africa medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Saudi Arabia medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. UAE medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Kuwait medical laser systems market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Product Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. LumIR Laser
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Boston Scientific Corporation
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Candela Corporation
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Koninklijke Philips N.V.
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. BIOLASE MG LLC. (MEGA'GEN IMPLANT CO.,LTD.)
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. IRIDEX Corporation
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. Biolitec Holding GmbH & Co KG
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. Olympus
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Product Benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. Cutera
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Product Benchmarking
      • 7.5.15.4. Strategic initiatives
    • 7.5.16. Alcon
      • 7.5.16.1. Company overview
      • 7.5.16.2. Financial performance
      • 7.5.16.3. Product Benchmarking
      • 7.5.16.4. Strategic initiatives
    • 7.5.17. Carl Zeiss Meditec AG
      • 7.5.17.1. Company overview
      • 7.5.17.2. Financial performance
      • 7.5.17.3. Product Benchmarking
      • 7.5.17.4. Strategic initiatives
    • 7.5.18. Bausch + Lomb
      • 7.5.18.1. Company overview
      • 7.5.18.2. Financial performance
      • 7.5.18.3. Product Benchmarking
      • 7.5.18.4. Strategic initiatives
    • 7.5.19. El.En. Sp.A.
      • 7.5.19.1. Company overview
      • 7.5.19.2. Financial performance
      • 7.5.19.3. Product Benchmarking
      • 7.5.19.4. Strategic initiatives
    • 7.5.20. Johnson & Johnson
      • 7.5.20.1. Company overview
      • 7.5.20.2. Financial performance
      • 7.5.20.3. Product Benchmarking
      • 7.5.20.4. Strategic initiatives
    • 7.5.21. Fotona
      • 7.5.21.1. Company overview
      • 7.5.21.2. Financial performance
      • 7.5.21.3. Product Benchmarking
      • 7.5.21.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제